What is GHK-Cu?

A copper complex of a three-amino-acid peptide, glycyl-L-histidyl-L-lysine (GHK).

At a glance

What it is
A copper complex of a three-amino-acid peptide, glycyl-L-histidyl-L-lysine (GHK).
Also called
copper tripeptide · copper peptide · glycyl-L-histidyl-L-lysine copper(II) · Copper tripeptide-1
US status
No compounding pathwayWe found no basis on which a pharmacy may compound it.
Evidence
D: Animal or in-vitro data onlyTopical: one small randomized study (13 patients completed) found no objective difference, several 12-week cream studies in 41 to 71 women are reported only in reviews by authors from a company that sells copper-peptide products, and one placebo-controlled diabetic-ulcer gel trial dates from 1994; injected: we found no human study of GHK-Cu alone.
Safety signal
Theoretical risk named by FDA or reviewsInjections: "risk for immunogenicity" from aggregation and peptide-related impurities, and "limited data in humans"No data (unknown ≠ safe)Long-term injected use, blends, pregnancy

Status checked Nov 16, 2026 · Injections

What the human evidence looks like

What the human evidence looks like
Kind of studyPeopleWhat was looked at
Randomized controlled trials13Measured: redness, wrinkles and skin quality on an objective rating, and patient satisfaction, in 13 patients who completed a randomized study of topical GHK-Cu after laser skin resurfacing (Miller 2006).15
Controlled studiesNot statedMeasured: closure of foot ulcers in people with diabetes, with a topical GHK-Cu gel against a placebo gel, in a multicenter trial with blinded evaluators; the abstract gives no patient count, and no approval followed (Mulder 1994).16
Open-label studies1,000An open-label, single-arm study in India gave 1,000 patients injections of a hair formulation that included copper tripeptide-1 with growth factors and other actives, so it cannot isolate GHK-Cu (Kapoor 2018); we found no human study of injected GHK-Cu alone.17
Open-label studiesNot statedA 15-day open-label study tested a scalp serum of copper tripeptide-1 with four other actives, by authors tied to its maker (Patel 2024); we found no placebo-controlled hair study of GHK-Cu.18

What the human evidence looks like
Kind of studyPeopleWhat was looked at
Registered trials60Registered phase 2 trial NCT07437586, recruiting, of a topical GHK-Cu gel against a placebo gel for acute skin wounds in 60 people; none of the 4 registered GHK-Cu studies tests injections.2223
Registered trials100Registered study of blood GHK levels with a patch, in 100 people, not yet recruiting; none of the 4 registered GHK-Cu studies tests injections.22
Registered trials48Registered study of a topical serum against an aging clock, in 48 people; none of the 4 registered GHK-Cu studies tests injections.22
Registered trials27Completed registered study of a facial device, in 27 people; none of the 4 registered GHK-Cu studies tests injections.22
ReviewsNot statedMeasured, in cream studies known only from reviews: collagen in thigh-skin biopsies (GHK-Cu, vitamin C or retinoic acid), facial skin over 12 weeks in 71 and in 67 women, and an eye cream over 12 weeks in 41 women against placebo and vitamin K; a 2015 review by authors at Skin Biology, a company selling copper-peptide products, reports them, and we did not find them as full papers in PubMed.1314
ReviewsNot statedA 2026 orthopedic review found no clinical data that support GHK-Cu for musculoskeletal conditions (Mayfield 2026).20

What programs claim, and what has been studied

What programs claim, and what has been studied
What programs claimWhat has been studiedGrade
Firmer skin, fewer wrinkles (topical)Small cream studies are reported only in reviews by authors tied to a maker, and one randomized study of 13 patients found no objective difference.1315D
Wound healing (topical)One placebo-controlled gel trial (1994) was not followed by an approval; a phase 2 trial is recruiting.1623C
Hair regrowthA lab study, a study of injections of a multi-ingredient formula, and a study of a multi-ingredient serum.171819F
Injections for skin, hair or "anti-aging"We found no human study of GHK-Cu alone.1721F

What programs claim, and what has been studied
What programs claimWhat has been studiedGrade
Joint, tendon or muscle recoveryA 2026 review found no clinical data.20F
AcneWe found no study.21F
"Resets 4,000 genes"Analyses of gene-expression databases, by authors tied to a maker.1314F
"FDA-approved"Not true: we found no FDA-approved GHK-Cu drug.10Contradicted

Safety facts

Reports to the FDA

  • The FDA's adverse event database (FAERS, read November 16, 2026) holds 2 reports that name GHK-Cu, both serious and from the US, and both list it as a product taken alongside, not the suspect; the reports are not checked and do not show cause. In June 2025, another drug was the suspect, and the report lists anaphylactic shock, loss of consciousness and low blood pressure, with a hospital stay; in May 2026, a GLOW blend appears with other drugs, and the terms include malignant lymphoid neoplasm and "product dispensed by unauthorised provider".12

What the FDA has said

  • The FDA says injectable GHK-Cu may pose "risk for immunogenicity due to the potential for aggregation and peptide-related impurities", and that there are "limited data in humans to inform safety-related considerations."3
  • Under MoCRA, the responsible person must report a serious adverse event from a cosmetic to the FDA within 15 business days.9

No data

  • We found no data on injected use of any length, pregnancy and breastfeeding, people with a history of cancer, children, or blends.321

Product quality

  • We found no published potency or contamination tests of GHK-Cu vials sold for injection.

Compounded GHK-Cu is prepared by a pharmacy to a prescription. It is not FDA-approved: the FDA doesn’t review its safety, effectiveness or quality before it’s sold.

You can report a side effect to the FDA through MedWatch.

What a trustworthy program shows

  • Requires a prescription, after a licensed prescriber evaluates youLegal
  • Names its state-licensed 503A pharmacy, with a license you can look upLegalGood practice
  • Says how its GHK-Cu product fits the FDA's lists: injectable GHK-Cu is on the "significant safety risks" page, and only non-injectable GHK-Cu is in Category 113LegalGood practice
  • Does not call it "FDA-approved", and does not present a skin-care serum as the same thing as a compounded drug710Legal
  • Does not sell it as "research use only"Legal
  • Gets the bulk ingredient from an FDA-registered facility, with a certificate of analysis2Legal
  • Sells a single ingredient, or names every active ingredient in a blend, and says blends are outside the HHS policy6Good practice
  • Explains side effects, allergy and cautions about copper, and how to report a side effect (MedWatch)Good practice
  • Makes no hair-regrowth or "regenerates cells" claims, which the FDA treats as drug claims under its intended-use test7LegalGood practice
  • Shows the price, renewal and cancellation terms before checkoutLegalGood practice
  • Tells athletes that WADA does not name GHK-Cu, but that class S0 may apply24Good practice

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
    Federal Register, FR Doc. 2026-22192, 91 FR 68526 (Oct 30, 2026)Tier 1: regulator or registergovinfo.govread Nov 16, 2026↩
  6. 6.
  7. 7.
    FDA: Is it a cosmetic, a drug, or both? (or is it soap?) (09/11/2024)Tier 1: regulator or registerfda.govread Nov 16, 2026↩
  8. 8.
  9. 9.
    FDA: Modernization of Cosmetics Regulation Act of 2022 (MoCRA) (10/29/2026)Tier 1: regulator or registerfda.govread Nov 16, 2026↩
  10. 10.
    openFDA Drugs@FDA search (GHK, prezatide: no matches)Tier 1: regulator or registerapi.fda.govread Nov 16, 2026↩
  11. 11.
    openFDA NDC directory, generic name GHK* (8 bulk ingredient listings)Tier 1: regulator or registerapi.fda.govread Nov 16, 2026
  12. 12.
    openFDA FAERS reports naming GHK-Cu (2 reports; data last updated Nov 13, 2026)Tier 1: regulator or registerapi.fda.govread Nov 16, 2026↩
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
    Patel MN et al. Scalp scrub and copper tripeptide serum regimen in seborrheic dermatitis. Cureus 2024;16(9):e70108Tier 2: peer-reviewed or trial registrypubmed.ncbi.nlm.nih.govread Nov 16, 2026↩
  19. 19.
    The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res 2007Tier 2: peer-reviewed or trial registrypubmed.ncbi.nlm.nih.govread Nov 16, 2026↩
  20. 20.
  21. 21.
    PubMed searches for GHK-Cu and copper-peptide terms (totals, animals, humans, trials, by period)Tier 2: peer-reviewed or trial registryeutils.ncbi.nlm.nih.govread Nov 16, 2026↩
  22. 22.
    ClinicalTrials.gov search for GHK-Cu (4 studies)Tier 2: peer-reviewed or trial registryclinicaltrials.govread Nov 16, 2026↩
  23. 23.
    NCT07437586: Topical GHK-Cu gel for acute skin wound healing (phase 2, recruiting)Tier 2: peer-reviewed or trial registryclinicaltrials.govread Nov 16, 2026↩
  24. 24.
    WADA Prohibited List 2026 (S0 non-approved substances)Tier 1: regulator or registerwada-ama.orgread Nov 16, 2026↩
  25. 25.
    DEA: Controlled substances, alphabetical order (Nov 12, 2026)Tier 1: regulator or registerdeadiversion.usdoj.govread Nov 16, 2026↩
  26. 26.
  27. 27.

We review programs, not peptides. This page reports what has been studied and what US regulators have said, with the source of each fact.

It is not medical advice: a decision about a medication is one to make with a licensed clinician.